Skip to content
value.today

Orthosensor Inc.

🇺🇸 Sunrise, Florida, USAHealth CareFounded 2007
Total raised
$94 M
11 rounds on record
Latest round
$2 M
Oct 2020
First round on record
Dec 2010
Today
Private
No later event on record

Funding rounds

11 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Orthosensor Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2020$2 MNo. 11Under $2 million

Orthosensor Inc.: Raise no. 11, Oct 2020

Investors in this round

1 investor had bought by the notice of Nov 12, 2020: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $16 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ivan Delevic · Executive Officer, Director
  • John Kyu Leo · Executive Officer
  • John Kyu Mastrototaro · Executive Officer
  • Jonathan Trousdale · Executive Officer
  • Martin Roche, MD · Executive Officer, Director
  • Roman Bensen · Executive Officer
  • Steve Kyu Seger · Executive Officer
  • Chang Kyu Kim · Director
  • Chris Kyu Dewey · Director
  • David Matlin · Director
  • Manuel Aguero · Director
  • Mark Baumgartner · Director
  • Michael Stansky · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Roman Bensen, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 12, 2020. Read the notice at the SEC.

debt, optionsSEC
Oct 2020$7 MNo. 10$2 to $10 million

Orthosensor Inc.: Raise no. 10, Oct 2020

Investors in this round

1 investor had bought by the notice of Oct 26, 2020: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ivan Delevic · Executive Officer, Director
  • John Kyu Leo · Executive Officer
  • John Kyu Mastrototaro · Executive Officer
  • Jonathan Trousdale · Executive Officer
  • Martin Roche, MD · Executive Officer, Director
  • Roman Bensen · Executive Officer
  • Steve Kyu Seger · Executive Officer
  • Chang Kyu Kim · Director
  • Chris Kyu Dewey · Director
  • David Matlin · Director
  • Manuel Aguero · Director
  • Mark Baumgartner · Director
  • Michael Stansky · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Roman Bensen, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 26, 2020. Read the notice at the SEC.

debt, optionsSEC
May 2019$6 MNo. 9$2 to $10 million

Orthosensor Inc.: Raise no. 9, May 2019

Investors in this round

8 investors had bought by the notice of May 28, 2020: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ivan Delevic · Executive Officer, Director
  • John Kyu Leo · Executive Officer
  • John Kyu Mastrototaro · Executive Officer
  • Jonathan Trousdale · Executive Officer
  • Martin Roche, MD · Executive Officer, Director
  • Roman Bensen · Executive Officer
  • Steve Kyu Seger · Executive Officer
  • Chang Kyu Kim · Director
  • Chris Kyu Dewey · Director
  • David Matlin · Director
  • Manuel Aguero · Director
  • Mark Baumgartner · Director
  • Michael Stansky · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Roman Bensen, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed May 28, 2020. Read the notice at the SEC.

debt, optionsSEC
Aug 2018$6 MNo. 8$2 to $10 million

Orthosensor Inc.: Raise no. 8, Aug 2018

Investors in this round

9 investors had bought by the notice of Nov 5, 2018: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ivan B. Delevic · Executive Officer, Director
  • John Kyu Leo · Executive Officer
  • Jonathan B. Trousdale · Executive Officer
  • Lalitendu Kyu Panda · Executive Officer
  • Martin Roche, MD · Executive Officer, Director
  • Roman B. Bensen · Executive Officer
  • Chang Kyu Kim · Director
  • David B. Matlin · Director
  • Manuel Aguero · Director
  • Mark B. Baumgartner · Director
  • Michael Stansky · Director
  • Steven B. Epstein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Roman Bensen, Chief Financial Officer. Source: SEC Form D and 2 amendments, newest notice filed Nov 5, 2018. Read the notice at the SEC.

debt, optionsSEC
Jan 2018$3 MNo. 7$2 to $10 million

Orthosensor Inc.: Raise no. 7, Jan 2018

Investors in this round

4 investors had bought by the notice of Apr 9, 2018: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ivan Charles Delevic · Executive Officer, Director
  • John Kyu Leo · Executive Officer
  • Jonathan Charles Trousdale · Executive Officer
  • Lalitendu Kyu Panda · Executive Officer
  • Martin Roche, MD · Executive Officer, Director
  • Roman Charles Bensen · Executive Officer
  • Chang Kyu Kim · Director
  • David B. Matlin · Director
  • Manuel Aguero · Director
  • Michael Stansky · Director
  • Stephen Charles O'Meara · Director
  • Steven B. Epstein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ivan Delevic, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 9, 2018. Read the notice at the SEC.

equity, optionsSEC
Apr 2017$6 MNo. 6$2 to $10 million

Orthosensor Inc.: Raise no. 6, Apr 2017

Investors in this round

15 investors had bought by the notice of Jul 14, 2017: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ivan Charles Delevic · Executive Officer, Director
  • Jonathan Charles Trousdale · Executive Officer
  • Lalitendu Kyu Panda · Executive Officer
  • Martin Roche, MD · Executive Officer, Director
  • Roman Charles Bensen · Executive Officer
  • Chang Kyu Kim · Director
  • David B. Matlin · Director
  • Manuel Aguero · Director
  • Michael Stansky · Director
  • Stephen Charles O'Meara · Director
  • Steven B. Epstein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Roman Bensen, Chief Financial Officer. Source: SEC Form D and 2 amendments, newest notice filed Jul 14, 2017. Read the notice at the SEC.

debt, optionsSEC
Apr 2016$2 MNo. 5$2 to $10 million

Orthosensor Inc.: Raise no. 5, Apr 2016

Investors in this round

11 investors had bought by the notice of Dec 29, 2016: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ivan Charles Delevic · Executive Officer, Director
  • Jonathan Charles Trousdale · Executive Officer
  • Roman Charles Bensen · Executive Officer
  • David B. Matlin · Director
  • Manuel Aguero · Director
  • Martin Roche, MD · Director
  • Michael Stansky · Director
  • Stephen Charles O'Meara · Director
  • Steven B. Epstein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Roman Bensen, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Dec 29, 2016. Read the notice at the SEC.

equity, optionsSEC
Nov 2015$4 MNo. 4$2 to $10 million

Orthosensor Inc.: Raise no. 4, Nov 2015

Investors in this round

9 investors had bought by the notice of Dec 9, 2015: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $12 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ivan B. Delevic · Executive Officer, Director
  • Marc B. Stein · Executive Officer
  • Roman B. Bensen · Executive Officer
  • Charles B. O'Meara · Director
  • David B. Matlin · Director
  • Manuel Aguero · Director
  • Martin Roche, MD · Director
  • Michael Stansky · Director
  • Steven B. Epstein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Roman Bensen, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 9, 2015. Read the notice at the SEC.

equity, optionsSEC
Nov 2014$17 MNo. 3$10 to $50 million

Orthosensor Inc.: Raise no. 3, Nov 2014

Investors in this round

32 investors had bought by the notice of Feb 27, 2015: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $19 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ivan Delevic · Executive Officer, Director
  • Marc D. Stein · Executive Officer
  • Martin Roche, Md · Executive Officer, Director
  • Roman D. Bensen · Executive Officer
  • Charles B. O'Meara · Director
  • David B. Matlin · Director
  • Floyd D. Loop, M.D. · Director
  • Manuel Aguero · Director
  • Michael Stansky · Director
  • Steven B. Epstein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Offering of Series C Convertible Preferred Stock.”

Signed by Roman Bensen, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 27, 2015. Read the notice at the SEC.

equity, optionsSEC
Mar 2013$12 MNo. 2$10 to $50 million

Orthosensor Inc.: Raise no. 2, Mar 2013

Investors in this round

39 investors had bought by the notice of Apr 11, 2014: 39 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $12 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jay Pierce · Executive Officer, Director
  • Marc D. Stein · Executive Officer
  • Martin Roche, Md · Executive Officer, Director
  • Roman D. Benson · Executive Officer
  • Charles B. O'Meara · Director
  • David B. Matlin · Director
  • Floyd D. Loop, M.D. · Director
  • Manuel Aguero · Director
  • Michael Stansky · Director
  • Steven B. Epstein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Offering of Series B-2 Convertible Preferred Stock.”

Signed by Jay Pierce, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Apr 11, 2014. Read the notice at the SEC.

equitySEC
Dec 2010$29 MNo. 1$10 to $50 million

Orthosensor Inc.: Raise no. 1, Dec 2010

Investors in this round

81 investors had bought by the notice of Apr 24, 2012: 81 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$29 M of $35 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jay Pierce · Executive Officer, Director
  • Charles C O'Meara · Director
  • Christopher C Dewey · Director
  • David C Matlin · Director
  • Floyd C Loop · Director
  • Manuel Aguero · Director
  • Martin Roche, Md · Director
  • Michael C Stansky · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • National Securities Corporation (CRD 7569) · broker-dealer Christopher C. Dewey (CRD 603620) · Seattle, WashingtonSold in all US states

Remarks in the notice

  • On the amounts: “The Total Offering Amount does not include $3,000,000 of Notes which will convert to Series B-1 Preferred Stock at the Initial Closing.”

Signed by Jay Pierce, President and CEO. Source: SEC Form D, newest notice filed Apr 24, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Orthosensor Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2020).

    SEC Form D · Nov 2020

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Nov 2020

That is all the official record says: Orthosensor Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Orthosensor Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 11 rounds above had up to 81 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Orthosensor Inc.
NameRoleNamed in
Ivan DelevicExecutive officerNov 2020
John Kyu LeoExecutive officerNov 2020
John Kyu MastrototaroExecutive officerNov 2020
Jonathan TrousdaleExecutive officerNov 2020
Martin Roche, MDExecutive officerNov 2020
Roman BensenExecutive officerNov 2020
Steve Kyu SegerExecutive officerNov 2020
Ivan B. DelevicExecutive officerNov 2018
Jonathan B. TrousdaleExecutive officerNov 2018
Lalitendu Kyu PandaExecutive officerNov 2018
Roman B. BensenExecutive officerNov 2018
Ivan Charles DelevicExecutive officerSep 2018
Jonathan Charles TrousdaleExecutive officerSep 2018
Roman Charles BensenExecutive officerSep 2018
Marc B. SteinExecutive officerDec 2015
Marc D. SteinExecutive officerFeb 2015
Martin Roche, MdExecutive officerFeb 2015
Roman D. BensenExecutive officerFeb 2015
Jay PierceExecutive officerApr 2014
Roman D. BensonExecutive officerApr 2014
Chang Kyu KimDirectorNov 2020
Chris Kyu DeweyDirectorNov 2020
David MatlinDirectorNov 2020
Ivan DelevicDirectorNov 2020
Manuel AgueroDirectorNov 2020
Mark BaumgartnerDirectorNov 2020
Martin Roche, MDDirectorNov 2020
Michael StanskyDirectorNov 2020
David B. MatlinDirectorNov 2018
Ivan B. DelevicDirectorNov 2018
Mark B. BaumgartnerDirectorNov 2018
Steven B. EpsteinDirectorNov 2018
Ivan Charles DelevicDirectorSep 2018
Stephen Charles O'MearaDirectorSep 2018
Charles B. O'MearaDirectorDec 2015
Floyd D. Loop, M.D.DirectorFeb 2015
Martin Roche, MdDirectorFeb 2015
Jay PierceDirectorApr 2014
Charles C O'MearaDirectorApr 2013
Christopher C DeweyDirectorApr 2013